- Home
- HNST vs LXEO Comparison
HNST vs LXEO Comparison
Compare HNST & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HNST | LXEO |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.3M | 396.5M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | HNST | LXEO |
|---|---|---|
| Price | $3.87 | $4.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $3.05 | ★ $18.44 |
| AVG Volume (30 Days) | ★ 1.2M | 962.4K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $371,317,000.00 | $654,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.07 | $3.60 |
| 52 Week High | $5.28 | $10.99 |
Technical Indicators
Market Signals| Indicator | HNST | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 48.43 |
| Support Level | $3.10 | $4.27 |
| Resistance Level | $4.04 | $5.36 |
| Average True Range (ATR) | 0.14 | 0.34 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 56.03 | 37.14 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.